Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
48.69
+1.19 (+2.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Crispr Therapeutics Ag
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Got the Market Sell-Off Blues? Do These 3 Things Right Now
August 11, 2024
You aren't powerless in the face of what the market throws at you.
Via
The Motley Fool
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
August 08, 2024
The "Mad Money" host says Dexcom had "a real bad miss... they still really haven't fully explained why that is."
Via
Benzinga
7 Biotech Stocks to Buy for Their Game-Changing Potential
August 08, 2024
Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.
Via
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in August 2024
August 07, 2024
These are the best gene-editing stocks to buy as the biotechs pursue precision therapies to cure rare diseases.
Via
InvestorPlace
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
August 06, 2024
Shares of the rare disease drugmaker are already up more than 40% over the past year.
Via
The Motley Fool
CRSP Stock Earnings: CRISPR Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 05, 2024
CRSP stock results show that CRISPR Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Prediction: These Could Be the Best-Performing Growth Stocks Through 2030
August 05, 2024
Great companies are found in every type of market landscape.
Via
The Motley Fool
Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker
August 04, 2024
The biotech recently became a commercial-stage company.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
10 Best Small and Mid-Cap Stocks to Consider Buying in August
August 01, 2024
A shift in market dynamics could favor these 10 growth stocks.
Via
The Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
July 31, 2024
The strugglingh stock investor did a little bit of shopping on Tuesday, adding to some of her existing positions.
Via
The Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
July 29, 2024
The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision.
Via
InvestorPlace
3 Small-Cap Stocks to Buy at a 52-Week Low
July 27, 2024
The Russell 2000 is hinting at sector rotation, meaning it’s time for bargain hunters to look for small-cap stocks at 52-week lows
Via
InvestorPlace
3 Gene Editing Stocks Shaping the Future of Medicine
July 22, 2024
Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions
Via
InvestorPlace
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
They're small now, but these stocks could grow much larger.
Via
The Motley Fool
3 Gene Editing Stocks That Could Grow Your Wealth
July 17, 2024
Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks.
Via
InvestorPlace
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
July 17, 2024
Explore gene-editing stocks with potential to become multibaggers as the industry advances in treating genetic disorders.
Via
InvestorPlace
Blue Chips, Small Caps Extending Their Breakout
July 16, 2024
The Dow Jones Industrial Average is stealing the show today, last seen up 546 points for a new record high and on track for its best single-session gain since January 2023.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
July 16, 2024
CRISPR Therapeutics could start reporting product revenue soon.
Via
The Motley Fool
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid
July 11, 2024
These two stocks could have vastly different long-term performances.
Via
The Motley Fool
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
July 11, 2024
In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance.
Via
Benzinga
Topics
ETFs
3 Profitable CRISPR Stocks Earning Analysts’ Praise
July 09, 2024
Revolutionary gene-editing technologies provide promise for investors seeking the most profitable CRISPR stocks today and in the future.
Via
InvestorPlace
7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030
July 09, 2024
Investing $500 in these seven high-growth stocks could potentially turn into $100,000 by 2030, offering massive upside.
Via
InvestorPlace
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
July 09, 2024
Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.
Via
InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.
Via
InvestorPlace
3 Pharma Stocks Already Ushering in the Next Biotech Boom
July 08, 2024
So long as diseases afflict the human condition, there will likely always be a need for pharma stocks. Here are three to consider.
Via
InvestorPlace
3 Top-Rated Gene Editing Stocks Actually Making Money
July 03, 2024
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.
Via
InvestorPlace
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
June 27, 2024
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.
Via
InvestorPlace
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
June 27, 2024
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.